Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Carisoprodol recalled?

Not under an active recall. Carisoprodol was recalled 6 times in the past — all now closed. Most recent: Jan 28, 2014.

Most common reason: Particulate / foreign matter (4 of these recalls)

Recalls are matched by product description. A recall usually affects specific lots, not every package of Carisoprodol. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Carisoprodol recalls on record

none so far in 2026; 6 on record, newest first
Class III · Low risk

Carisoprodol Tablets

Failed Impurity/degradation Specification

Terminated Impurity / degradation Mylan Institutional, Inc. (d.b.a. UDL Laboratories) NDC 51079-819-20 D-1155-2014
Class II · Moderate risk

Carisoprodol Tablets

Presence of Foreign Substance; metal particulates were visually observed in the tablets.

Terminated Particulate / foreign matter Watson Laboratories Inc NDC 0591-5513-05 D-397-2014
Class II · Moderate risk

Carisoprodol IV

Presence of Foreign Substance; heavy metals (chromium, titanium etc) and inactive components of the product were visually observed during routine stability testing.

Terminated Particulate / foreign matter Physicians Total Care, Inc. D-390-2014
Class II · Moderate risk

Carisoprodol Tablets

Presence of Foreign Substance; heavy metals (chromium, titanium etc) and inactive components of the product were visually observed during routine stability testing

Terminated Particulate / foreign matter West-Ward Pharmaceutical Corp. NDC 0143-9749-10 D-367-2014
Class III · Low risk

Carisoprodol Tablets

Labeling: Not elsewhere classified: On 12/12/11, DEA published a final rule in the Federal Register making this product a schedule IV (C-IV)controlled substance. This product is being recalled because this controlled product was not relabeled with the required "C-IV" imprint on the label for products distributed after the 06/11/12 deadline.

Terminated Labeling / mix-up West-ward Pharmaceutical Corp. NDC 0143-1176-01 D-201-2013